EICHOR
● Active Not Recruiting
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Condition: Malignant Solid Tumor · Non-Small Cell Lung Cancer (NSCLC) · Colorectal Cancer (CRC) · Sponsor: Genmab
About this study
The goal of this trial is to learn about the antibody GEN1042 when it is used alone and when it is used together with another antibody cancer drug, pembrolizumab (with or without chemotherapy), for treatment of participants with certain types of cancer.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (76)
| Alaska Oncology and Hematology LLC | Anchorage, Alaska, United States | — |
| Cancer & Blood Specialty Clinic | Los Alamitos, California, United States | — |
| Moores Cancer Center at the UC San Diego Health | San Diego, California, United States | — |
| Yale University Cancer Center | New Haven, Connecticut, United States | — |
| ChristianaCare | Newark, Delaware, United States | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach, Florida, United States | — |
| Florida Cancer Affiliates | Ocala, Florida, United States | — |
| Hope and Healing Cancer Services | Hinsdale, Illinois, United States | — |
| University of Kentucky | Lexington, Kentucky, United States | — |
| Norton Cancer Institute | Louisville, Kentucky, United States | — |
| Maryland Oncology Hematology PA | Columbia, Maryland, United States | — |
| Washington University School of Medicine | St Louis, Missouri, United States | — |
+ 64 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04083599